US4230708A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Therapeutic application of (S) -or (RS)-9-(2, 3-dihydroxypropyl) adenine for use as antiviral agents
Assignee: Stichting Rega VZW
•
Filing: 1978-10-20
•
Granted: 1980-10-28
•
Expires: 1998-10-20
Abstract
Abstract The specification describes the use of S or RS 9-(2, 3-dihydroxypropyl) adenine either alone or in combination with ara-A for the treatment of virus diseases.
Inventors
- 👤 Erik De Clercq
- 👤 Antonin Holy
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-29 22:53
CPC Classifications
C; C07; C07D; C07D473/00; C07D473/26; C07D473/32; C07D473/34
Claims Analysis
Total Claims: 3
Claim 1
Independent Claim
35 words
A method for the treatment of viral diseases which comprises administering a therapeutically effective amount of a compound selected from the group consisting of (S)-9-(2,3-dihydroxypropyl)adenine and (RS)-9-(2,3-dihydroxypropyl)adenine to a patient suffering from a viral disease.
Claim 2
Independent Claim
35 words
A method for the treatment of viral diseases which comprises administering a therapeutically effective amount of a compound selected from the group consisting of (S)-9-(2,3-dihydroxypropyl)adenine and (RS)-9-(2,3-dihydroxypropyl)adenine to a patient suffering from a viral disease.
Claim 3
Dependent Claim
23 words
The method described in claim 1 wherein the virus is selected from the group consisting of vaccinia, herpes simplex, measles and vesicular stomatitis.
References Cited (Backward Citations)
US3836656A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1983-10-28 | 1984-04-28 | 1984-10-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1987-10-28 | 1988-04-28 | 1988-10-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1991-10-28 | 1992-04-28 | 1992-10-28 | $7700.00 | Window Closed / Lapsed |